Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
BMC Sports Science, Medicine & Rehabilitation|September 16, 2025
Optimizing cardiorespiratory fitness after bariatric surgery - highly effective with very low adherence: HIT BAR randomized controlled trialAlida Finze, Megan Duddek, Svetlana Hetjens, et al.
Obesity Surgery|June 15, 2026
Preoperative Use of a Mobile Application Within the Multidisciplinary Team Approach - A Randomized Controlled Clinical TrialCeline Kadesch, Christel Weiss, Michael Hetjens, et al.
Surgical Oncology|July 8, 2017
The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinomaLeila Sisic, Susanne Blank, Henrik Nienhüser, et al.
Oncology Research and Treatment|April 2, 2014
Clinically staged cT2 adenocarcinomas of the gastroesophageal junction: accuracy of staging and therapeutic consequencesDaniel Vallböhmer, Leila Sisic, Susanne Blank, et al.
Anesthesiology|May 24, 2023
Individualized Positive End-expiratory Pressure Titration Strategies in Superobese Patients Undergoing Laparoscopic Surgery: Prospective and Nonrandomized Crossover StudyChristoph Boesing, Laura Schaefer, Marvin Hammel, et al.
Gastrointestinal Endoscopy|September 1, 2024
Endoscopic vacuum therapy for the treatment of Boerhaave syndrome: a multicenter analysisAndreas Wannhoff, Konstantinos Kouladouros, Ronald Koschny, et al.
Frontiers in Oncology|September 5, 2022
Robot-assisted esophagectomy may improve perioperative outcome in patients with esophageal cancer - a single-center experienceJohanna Betzler, Lea Elfinger, Sylvia Büttner, et al.
Oncology Letters|December 2, 2015
Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancerLeila Sisic, Daniel Vallböhmer, Nikolas H Stoecklein, et al.
BMC Cancer|February 5, 2014
A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patientsSusanne Blank, Sivaramakrishna Rachakonda, Gisela Keller, et al.
Annals of Surgical Oncology|June 2, 2018
Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric AdenocarcinomasUlrike Heger, Leila Sisic, Henrik Nienhüser, et al.
Pageof 5